Observational studyBMC public health2025
Potentially disabling factors of newly diagnosed leprosy patients in southwest China: a retrospective observational study.
Observational study in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Leprosy-Related Stigma and Social Representations Among Persons Affected by Leprosy and Primary Healthcare Professionals: A Structural Analysis in the Brazilian Amazon.Journal of community health · 2026Article
- Analysis of the status of leprosy symptom surveillance in Guangdong province: an exploring effort to promote early detection.BMC public health · 2025Article
- Vitamin B12 and D3 Levels in Leprosy Patients With or Without Deformity: A Cross-Sectional, Analytic Study.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWith the prevalence of leprosy dramatically declining, the focus of leprosy control has gradually shifted from the implementation of multidrug therapy (MDT) to accelerating the reduction of the disease burden and preventing disability. Southwestern China currently bears the highest leprosy burden in China and more than half of the disability cases reported every year are from this region. However, the potential risk factors of leprosy disability in this area remain unknown.
methodsIn this study, we evaluated the physical disabilities of 4578 leprosy patients in southwest China from 2010 to 2020. Clinical and epidemiological factors associated with physical disability resulting from leprosy were identified using multinomial logistic regression.
resultsA total of 4578 leprosy cases with complete information were reported in southwestern China during the 11 years. Among them, 1126 (24.60%) patients were diagnosed with grade 2 disability (G2D), and 737 (16.10%) were confirmed with grade 1 disability (G1D) at diagnosis. The potential factors associated with G2D are as follows: nerve damage, male, leprosy reaction, older age of the patient, the longer delay in diagnosis, and more skin lesions. Furthermore, nerve damage, leprosy reaction, male, older age, and longer delayed diagnosis were the main risk factors of G1D. Among them, nerve damage, older age, longer delayed diagnosis, male, and leprosy reaction were the common risk factors for G1D and G2D.
conclusionIn our study, we found older age, longer delayed diagnosis, male, more skin lesions, more nerve lesions, and leprosy reactions were associated with leprosy disability. These findings provide a foundation for the development of targeted interventions aimed at the early identification of individuals at higher risk of physical disability, as well as for self-care and health education to promote timely medical consultation to prevent leprosy-related disabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.